VERE HODGE ANTIVIRALS LIMITED

Company Registration Number:
03245006 (England and Wales)

Unaudited micro entity accounts for the year ended 30 April 2024

Period of accounts

Start date: 01 May 2023

End date: 30 April 2024

VERE HODGE ANTIVIRALS LIMITED

Contents of the Financial Statements

for the Period Ended 30 April 2024

Company Information - 3
Profit and Loss Account - 4
Balance sheet - 5
Footnotes to the Balance Sheet - 7

VERE HODGE ANTIVIRALS LIMITED

Company Information

for the Period Ended 30 April 2024




Registered office: Old Denshott
Flanchford Road Leigh
Reigate
Surrey
RH2 8RD
Company Registration Number: 03245006 (England and Wales)

VERE HODGE ANTIVIRALS LIMITED

Profit and Loss Account

for the Period Ended 30 April 2024


2024
£

2023
£
Turnover 0 0
Income from coronavirus (COVID-19) business support grants 0 0
Other Income 0 0
Cost of Materials ( 962 ) ( 2,515 )
Staff Costs ( 0 ) ( 0 )
Depreciation and Writeoffs ( 0 ) ( 0 )
Other charges ( 13 ) ( 13 )
Tax on Profit ( 0 ) ( 0 )
Profit or (Loss) for Period ( 975 ) ( 2,528 )

VERE HODGE ANTIVIRALS LIMITED

Balance sheet

As at 30 April 2024


2024
£

2023
£
Called up share capital not paid: 0 0
Fixed Assets: 0 0
Current assets: 5,361 5,574
Prepayments and accrued income: 0 0
Creditors: amounts falling due within one year: ( 51 ) ( 188 )
Net current assets (liabilities): 5,310 5,386
Total assets less current liabilities: 5,310 5,386
Creditors: amounts falling due after more than one year: ( 78,290 ) ( 77,490 )
Provision for liabilities: ( 0 ) ( 0 )
Accruals and deferred income: ( 0 ) ( 0 )
Total net assets (liabilities): ( 72,980 ) ( 72,104 )
Capital and reserves: ( 72,980 ) ( 72,104 )

VERE HODGE ANTIVIRALS LIMITED

Balance sheet continued

For the year ending 30 April 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 16 January 2025
And Signed On Behalf Of The Board By:

Name: Richard Anthony Vere Hodge
Status: Director

The notes form part of these financial statements

VERE HODGE ANTIVIRALS LIMITED

Footnotes to the Financial Statements

for the Period Ended 30 April 2024

  • 1. Employee Information

    Average number of employees: 0

VERE HODGE ANTIVIRALS LIMITED

Footnotes to the Financial Statements

for the Period Ended 30 April 2024

  • 2. Off balance sheet disclosure

    No